| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/28/1993 | EP0453456B1 Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them |
| 04/28/1993 | EP0403601B1 Novel somatotropins |
| 04/28/1993 | CN1071333A Calcium receptor active molecules |
| 04/27/1993 | US5206384 Actinonin derivatives and pharmaceutically acceptable salts thereof |
| 04/27/1993 | US5206354 Dna sequence encoding active fragment of fibroblast growth factor, hbf-2 |
| 04/27/1993 | US5206353 Viricides |
| 04/27/1993 | US5206352 Compositions for clones containing DNA sequences associated with multidrug resistance in human cells |
| 04/27/1993 | US5206345 Binding specifically to epitope of cell surface; monoclonal antibodies and antigen-binding fragments |
| 04/27/1993 | US5206344 Using polyethylene glycol |
| 04/27/1993 | US5206343 Oligopetides with cyclic proline-analogous amino acids |
| 04/27/1993 | US5206235 Animal growth regulators; stimulants |
| 04/27/1993 | US5206234 Benzolactam analogs as antagonists of cck |
| 04/27/1993 | US5206221 Removal of cytotoxic lymphocytes |
| 04/27/1993 | US5206219 Oral compositions of proteinaceous medicaments |
| 04/27/1993 | US5206218 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 04/27/1993 | US5206161 Polypeptide having in its mature form the N-terminal sequence PheGluSer; useful in medical diagnosis |
| 04/27/1993 | US5206160 Composition containing buf-3 and superoxide dismutase as a cell cleavage promoting agent |
| 04/27/1993 | US5206156 Lactoperoxidase bonded to carrier of hydrophilic saccharide with lipid and phospholipid layers, oxygen donor, oxidizable substrate; food and medical uses |
| 04/27/1993 | US5206023 Method and compositions for the treatment and repair of defects or lesions in cartilage |
| 04/27/1993 | US5206017 Reducing loss of glycosaminoglycans in connective tissue |
| 04/27/1993 | US5206014 Activating antibody response |
| 04/27/1993 | US5206008 Using androstene(diol or triol) |
| 04/27/1993 | CA1317070C Inhibitor peptides i and ii |
| 04/27/1993 | CA1317069C2 Synthetic peptides having pituitary growth hormone releasing activity |
| 04/27/1993 | CA1317068C Peptides influencing diuresis and natriuresis, a process for their preparation, agents containing them, and their use |
| 04/27/1993 | CA1316848C Monoclonal antibody recognizing un-natural ganglioside gd |
| 04/27/1993 | CA1316832C Treatment of human viral infection by dsrna combined with viral inhibitors |
| 04/22/1993 | CA2080891A1 Peg imidates and protein derivatives thereof |
| 04/22/1993 | CA2080538A1 Lyophilized acidic fibroblast growth factor |
| 04/22/1993 | CA2080537A1 Stabilized topical acidic fibroblast growth factor formulation |
| 04/21/1993 | EP0538030A2 Novel neutrophil activating factors |
| 04/21/1993 | EP0538027A2 Cyclohexapeptides |
| 04/21/1993 | EP0538002A1 Aminoalkyl thioether compounds |
| 04/21/1993 | EP0537722A2 Porcane liver polypeptides for treating viral infections |
| 04/21/1993 | EP0537654A2 Anti-alpha6-integrin-antibodies |
| 04/21/1993 | EP0537634A2 Iron complexes containing conalbumin and its derivatives |
| 04/21/1993 | EP0537489A1 Monoclonal antibodies against tumor-associated antigens, method for their preparation and their use |
| 04/21/1993 | EP0537437A2 Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines |
| 04/21/1993 | EP0537325A1 Enzymatic neutralization of heparin |
| 04/21/1993 | EP0537318A1 New non-hygroscopic mono-ammonium salts. |
| 04/21/1993 | EP0537293A1 Ligand for cd28 receptor on b cells and methods |
| 04/21/1993 | EP0537291A1 Method of treating nausea and emesis related to motion sickness |
| 04/21/1993 | EP0537276A1 Cancer-associated scm-recognition factor, preparation and method of use |
| 04/21/1993 | EP0537199A1 Compositions for treating hiv-type 1 infection |
| 04/21/1993 | EP0537191A1 Treatment of organ transplantation rejection |
| 04/21/1993 | EP0537171A1 Cd46 variants |
| 04/21/1993 | EP0537166A1 Water-soluble polypeptides having high affinity for interferons alpha and beta |
| 04/21/1993 | EP0537160A1 Expression of recombinant hemoglobin in yeast |
| 04/21/1993 | EP0526570A4 Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents |
| 04/21/1993 | EP0476038B1 Chemical products |
| 04/21/1993 | EP0407401B1 Human relaxin formulation |
| 04/21/1993 | EP0343248B1 Novel polypeptide and method for preparing the same |
| 04/20/1993 | US5204462 4h-3,1-benzoxazin-4-one derivative |
| 04/20/1993 | US5204452 N-halochitosans, their preparation and uses |
| 04/20/1993 | US5204450 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 04/20/1993 | US5204446 Polypeptide having immunoreactivity with antibody specific to hepatitis b virus |
| 04/20/1993 | US5204445 Peptides and antibodies that inhibit integrin-ligand binding |
| 04/20/1993 | US5204329 4-Quinoline carboxylic acid derivatives |
| 04/20/1993 | US5204328 N-methylated analogs of atriopeptin having increased potency and metabolic stability; hypotensive agents; vasodilation; congestive heart failure; renal hypertension |
| 04/20/1993 | US5204327 Treatment of cerebral edema with anp pharmaceutical compositions |
| 04/20/1993 | US5204326 Analgesics, antiulcer agents, lowering calcium absorption |
| 04/20/1993 | US5204325 Viscoelastic solution |
| 04/20/1993 | US5204323 Heparin and hirudin antidotal compositions and methods |
| 04/20/1993 | US5204321 Heparin neutralization with platelet factor 4 |
| 04/20/1993 | US5204259 Methods and systems for producing HIV antigens |
| 04/20/1993 | US5204258 DNA segment not expressing functional tat protein having ability to trans-activate; not containing entire HIV genome; for developing vaccines, detecting HTLV |
| 04/20/1993 | US5204255 Hybrid tissue plasminogen activator/urokinase polypeptides |
| 04/20/1993 | US5204114 Using crystalline ascorbic acid as an antistatic agent |
| 04/20/1993 | US5204108 Microspheres |
| 04/20/1993 | US5204103 Using vegetable fiber from Plantago ovata with holder for applying to skin; ulcers |
| 04/20/1993 | US5204095 Monoclonal antibodies against hepatitis B virus |
| 04/20/1993 | US5204094 Administering polypeptide having interleukin-2 activity |
| 04/20/1993 | CA1316630C Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides |
| 04/19/1993 | CA2078817A1 Anti-.alpha.6-integrin-antibodies |
| 04/18/1993 | CA2080759A1 Aminoalkylamides |
| 04/18/1993 | CA2080757A1 Aminoalkyl thioether compounds |
| 04/18/1993 | CA2080756A1 1-(4-hydroxy-5-aminoethyloxy-n2- (10,12-dimethyl-1-oxotetraecyl) ornithine)-5(3-hydroxyglutamine) -6-(3-hydroxyproline) echinocandin |
| 04/17/1993 | WO1993008213A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine |
| 04/17/1993 | WO1993007892A1 Composition and treatment with biologically active peptides and antibiotic |
| 04/17/1993 | CA2120337A1 Composition and treatment with biologically active peptides and antibiotic |
| 04/17/1993 | CA2080525A1 Neutrophil activating factors |
| 04/15/1993 | WO1993007485A1 Rare immunoglobulin framework regions associated with human disease |
| 04/15/1993 | WO1993007288A1 Macrophage activating factor from animal vitamin d-binding protein |
| 04/15/1993 | WO1993007286A1 Recombinant immunotoxins |
| 04/15/1993 | WO1993007283A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/15/1993 | WO1993007274A1 Molecular cloning of pneumocystis carinii surface antigens and their use for the detection of pneumocystis carinii |
| 04/15/1993 | WO1993007273A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof |
| 04/15/1993 | WO1993007271A1 Osteoclast colony stimulating factor (o-csf) |
| 04/15/1993 | WO1993007270A1 Production of gpa neurotrophic factor |
| 04/15/1993 | WO1993007268A1 Soluble forms of elam, uses and diagnostics |
| 04/15/1993 | WO1993007265A1 Treatment of cystic fibrosis |
| 04/15/1993 | WO1993007172A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits |
| 04/15/1993 | WO1993007171A1 Human il-3 variants |
| 04/15/1993 | WO1993007170A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 04/15/1993 | WO1993007169A1 Peptide inhibitors of platelet adhesion |
| 04/15/1993 | WO1993007165A1 Lipoprotein assays using antibodies to a pan native epitope and recombinant antigens |
| 04/15/1993 | WO1993006872A1 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
| 04/15/1993 | WO1993006867A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/15/1993 | WO1993006866A2 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 04/15/1993 | WO1993006865A1 Treatment of ocular inflammation by blockage of cell adhesion molecules |